|Articles|December 14, 2004

DECSpotlight

Newsletter

Get the essential updates shaping the future of pharma manufacturing and compliance. Subscribe to Pharmaceutical Technology and never miss an industry breakthrough.

Subscribe

Related Content

PharmTech Weekly Roundup—September 4, 2026

BySusan Haigney

September 4th 2026

AAPS PharmSci 360: CMC Strategies, Part 1

ByAlfred Rumondor, PhD,Swita Singh, PhD,Susan Haigney

September 2nd 2026

Medical award concept, winner cup on the desk | Image Credit: ©BillionPhotos.com -stock.adobe.com

CPHI Milan Names 2026 Pharma Awards Finalists

BySusan Haigney

September 1st 2026

Regulatory Roundup—August 2026

BySusan Haigney

August 31st 2026

n-nitrosodimethylamine molecular structure, 3d model molecule, dimethylnitrosamine, structural chemical formula view from a microscope | Image Credit: ©Сергей Шиманович -stock.adobe.com

From Detection to Prediction: Analytical Approaches for Nitrosamine Risk

ByChris Williams

August 31st 2026

DECSpotlight

Related Content

PharmTech Weekly Roundup—September 4, 2026

AAPS PharmSci 360: CMC Strategies, Part 1

CPHI Milan Names 2026 Pharma Awards Finalists

Regulatory Roundup—August 2026

From Detection to Prediction: Analytical Approaches for Nitrosamine Risk

Trending on Pharmaceutical Technology

CAR T-Cell Trial Pause Signals New Manufacturing Risk Review

CPHI Milan Names 2026 Pharma Awards Finalists

Application of Predictive Modeling in the Development of Amorphous Solid Dispersions

AAPS PharmSci 360: CMC Strategies, Part 1

What Novartis's $3.2 Billion Enzyme Licensing Deal Means for Formulation